Paolo Tarantino: Dato-DXd is the Latest ADC to Be Approved for Treating HR+/HER2- MBC

OncoDaily Oncology cancer fight against cancer Global fight against cancer cancer care ASCO Breast Cancer Cancer research Lung cancer MD Anderson Cancer Center cancer awareness ESMO Research ASCO24 cancer treatment NSCLC immunotherapy Headlines AACR prostate cancer colorectal cancer Childhood Cancer clinical trials FDA Dana-Farber Cancer Institute American Cancer Society NCI European Cancer Organisation UICC National Cancer Institute healthcare SIOP chemotherapy Vivek Subbiah American Society of Clinical Oncology AI WHO ASCO25 Paolo Tarantino Zainab Shinkafi-Bagudu Memorial Sloan Kettering Cancer Center multiple myeloma patient care American Association for Cancer Research cervical cancer Robert Orlowski radiation oncology Sylvester Comprehensive Cancer Center IASLC Sitemap All Tags »